From the Research
Travocort is not currently available in Canada. This medication, which contains the active ingredients isoconazole nitrate (an antifungal) and diflucortolone valerate (a corticosteroid), is used in some countries to treat fungal skin infections with inflammatory components. Canadian patients requiring similar treatment would need to use alternative combination antifungal-corticosteroid products that are approved in Canada, such as Lotriderm (clotrimazole and betamethasone) or separate antifungal and corticosteroid medications used together.
Key Points to Consider
- The unavailability of Travocort in Canada is due to differences in drug approval and marketing between countries, as pharmaceutical companies must obtain separate regulatory approval for each market they wish to sell their products in 1, 2, 3, 4, 5.
- If you're seeking treatment for a fungal skin infection with inflammation, it's essential to consult with a Canadian healthcare provider who can prescribe appropriate alternatives available in the Canadian market.
- The provided evidence does not directly address the availability of Travocort in Canada, but it highlights the importance of consulting with a healthcare provider for appropriate treatment options.
- Studies have shown that topical corticosteroids are effective in treating atopic dermatitis, but their use should be carefully considered due to potential side effects 4.
- The International Eczema Council consensus statement recommends avoiding systemic corticosteroids for atopic dermatitis, but they can be used in rare cases under certain circumstances 5.